The latest edition of Inselspital's “Ärztemagazin” reports on their adoption of the alfapump system for patients with cirrhotic ascites. The project has been funded from the hospital ‘Innovationsfond’.
This year’s Healthtech Summit took place on 25 and 26 June at the NYSE Euronext in London. The event focused on the top 20 healthcare, lifescience and medtech companies in Europe. The theme of the event was: Crossing the chasm from startup to a sustainable high growth business. This event was a showcase of the best European entrepreneurs and provided significant visibility and media coverage for the selected companies.
The case study, reported by the Ovarian Cancer Action Research Centre at Imperial College NHS Trust, London, is presented at this year's American Society of Clinical Oncology. Read the abstract here.
Inselmagazin, the in-house magazine for the University Hospital Bern interviews Dr. Andrea De Gottardi on his experiences with the alfapump system. Read the article here.
Sequana Medical will be presenting the alfapump system at this year’s International Liver Congress in Amsterdam, taking place from the 24th to 28th of April. Visit us in the exhibition hall at stand 28.
University of Modena and Reggio Emilia implant Italy’s first patients with Sequana Medical’s alfapump® system
Swiss company’s innovative technology for the management of refractory ascites significantly reduces the need for large-volume paracentesis.
Dr. Noel L. Johnson and Professor Hani Gabra present the alfapump® system at the Royal Society of Medicine Innovations Summit
Dr Noel L. Johnson, President and CEO of Sequana Medical, and Professor Hani Gabra, honorary consultant in medical oncology, Hammersmith Hospital, and director, Overian Cancer Action Research Centre, were invited to present the alfapump system and its role in the management of malignant ascites at Royal College of Medicine's annual Medical Innovations summit.
Watch the podcast here.
German TV channel MDR reported on the alfapump experience at the University Hospital of Leipzig. To watch the report (in German), visit our video section on alfapump.com.
'The Times' reports on first alfapump® implant in patient with malignant ascites due to ovarian cancer
UK national newspaper The Times describes the alfapump as 'game-changing technology' in this report on the first ever alfapump implant in a patient with ovarian cancer. Read the article.
Listen to a report broadcast on Deutschlandradio about the alfapump experience at Hannover Medical School (in German).